Data / Form D filings / Qlaris Bio, Inc.
Qlaris Bio, Inc.: Form D filings
Qlaris Bio, Inc., a biotechnology company in Dedham, MA, filed 4 Form D notices with the SEC between 2019 and 2026. The latest, on June 17, 2026, reports $3.9 million sold of a $3.9 million offering to 8 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 770 Legacy Place 2nd Floor, Dedham, MA, 02026
- Phone
- (917) 217-7007
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1786717
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | New notice | $3,946,659 | $3,946,659 | 8 | Jun 12, 2026 | sec.gov | |
| Nov 17, 2025 | New notice | $5,641,600 | $5,641,600 | 8 | Nov 13, 2025 | sec.gov | |
| Apr 22, 2024 | New notice | $24,032,554 | $24,032,554 | 8 | Apr 11, 2024 | sec.gov | |
| Aug 28, 2019 | New notice | $27,325,180 | $8,164,654 | $19,160,526 | 6 | Aug 13, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Frederic Guerard | Executive Officer, Director | |
| Andrew Danielson | Director | |
| Adrienne Graves | Director | |
| Ronald M. Hunt | Director | |
| Wende Hutton | Director | |
| Barbara Wirostko | Executive Officer | |
| Robert Warner | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jun 15, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Qlaris Bio, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.